Literature DB >> 22576684

Differential expression of aquaporin 5 and aquaporin 3 in squamous cell carcinoma and adenoid cystic carcinoma.

Shunsuke Ishimoto1, Koichiro Wada, Yu Usami, Noriaki Tanaka, Tomonao Aikawa, Masaya Okura, Atsushi Nakajima, Mikihiko Kogo, Yoshinori Kamisaki.   

Abstract

Aquaporins (AQPs) are a membrane protein family involved in the selective transport of water across cell membranes. Recent studies have reported the expression of AQP5 in several tumor types such as gastric, pulmonary, ovarian, pancreatic and colorectal cancer. We have previously reported the expression on tumor cells and the important role of AQP3 on cell growth in tongue cancer. However, little is known about the expression and precise role of AQP5 on squamous cell carcinoma (SCC) of the tongue. We investigated the expression of AQP5 and AQP3 in human oral SCC and adenoid cystic carcinoma (ACC). Overexpression of both AQP5 and AQP3 were immunohistochemically observed on tumor cells in SCC, whereas ACC cells were faintly stained with those antibodies against AQPs. Treatment with pan-AQP inhibitor or specific AQP5-siRNA showed inhibition of cell growth in SCC cell lines via the inhibition of integrins and the mitogen-activated protein kinase pathway. AQPs play important roles in cell growth in SCC rather than ACC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576684     DOI: 10.3892/ijo.2012.1445

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  17 in total

Review 1.  Role of aquaporins in cell proliferation: What else beyond water permeability?

Authors:  Ana Galán-Cobo; Reposo Ramírez-Lorca; Miriam Echevarría
Journal:  Channels (Austin)       Date:  2016-01-11       Impact factor: 2.581

2.  AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells.

Authors:  Xiaoming Shi; Shengchun Wu; Yongbin Yang; Lei Tang; Yüexin Wang; Junjie Dong; Bonan Lü; Guangwei Jiang; Wei Zhao
Journal:  Tumour Biol       Date:  2014-04-23

3.  Expression of aquaporin 8 and phosphorylation of Erk1/2 in cervical epithelial carcinogenesis: correlation with clinicopathological parameters.

Authors:  Heng Chang; Yonghua Shi; Talaf Tuokan; Rui Chen; Xiaoqian Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis.

Authors:  Sulin Liu; Shuyao Zhang; Hong Jiang; Yuxian Yang; Yi Jiang
Journal:  Med Oncol       Date:  2013-06-25       Impact factor: 3.064

Review 5.  Deciphering the structure, function, expression and regulation of aquaporin-5 in cancer evolution.

Authors:  Liping Wang; Da Huo; Haiyan Zhu; Qian Xu; Chengpeng Gao; Wenfeng Chen; Yixiang Zhang
Journal:  Oncol Lett       Date:  2021-02-21       Impact factor: 2.967

Review 6.  Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application.

Authors:  Nagore Del-Río-Ibisate; Rocío Granda-Díaz; Juan P Rodrigo; Sofía T Menéndez; Juana M García-Pedrero
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

7.  Expression of AQP3 and AQP5 as a prognostic marker in triple-negative breast cancer.

Authors:  Zhengcai Zhu; Lianghe Jiao; Tao Li; Honggang Wang; Wei Wei; Haixin Qian
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

Review 8.  Aquaporin-5: from structure to function and dysfunction in cancer.

Authors:  Inês Direito; Ana Madeira; Maria Alexandra Brito; Graça Soveral
Journal:  Cell Mol Life Sci       Date:  2016-02-02       Impact factor: 9.261

9.  AQP2 as a diagnostic immunohistochemical marker for pheochromocytoma and/or paraganglioma.

Authors:  Dongfeng Niu; Yanhua Bai; Qian Yao; Lixin Zhou; Xiaozheng Huang; Chen Zhao
Journal:  Gland Surg       Date:  2020-04

10.  Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer.

Authors:  Nathaniel Melling; Johanna Muth; Ronald Simon; Carsten Bokemeyer; Luigi Terracciano; Guido Sauter; Jakob Robert Izbicki; Andreas Holger Marx
Journal:  Diagn Pathol       Date:  2015-07-25       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.